Tarama testi olarak gebelerde glikoz screening uygulaması

Aralık 1998 ile Aralık 1999 tarihleri arasında polikliniğe başvuran 24. Gebelik haftasını aşmış 825 gebeye Gestasyonel diabet sıklığını ortaya çıkarmak amacı ile 50 gr'lık glikoz tarama testi uyguladık. 135 mg/dl üzerindeki test değerlerine Oral Glikoz Tolerans Testi (OGTT) uyguladık. Pozitif screening test oranımız % 4.965 pozitif OGTT oranımız ise % 1.212 düzeyinde gerçekleşti. Eşik değer olarak 140 mg/dl seçildiğinde testin spesifitesi %99'a sensivitesi % 100'e pozitif prediktif değeri ise % 62'ye yükseldi. Yaş parite ve tokluk durumunun testin sonucunu değiştirmediği gözlendi. Bu nedenle 24. Gebelik haftasını geçen tüm gebelere 50 gr glikoz tarama testi uygulanması güvenli ve kolay uygulanabilir bir yöntem olarak kabul edildi.

Glucose challenge test as a screening method in pregnancy

We have studied 50 gr -1 hour glucose screening test to diagnose gestational diabetes mellitus incidence in our clinics between 01.01.99-01.12.99. Screening test was given to 825 gravid women. All women were screened at 24 weeks and above. 4.969 % were found positive for screening test and 1.212 % were to be diabetic. If threshold was chosen as 140 mg/dl, specifity of the test was 99% and sensitivity was 100 %. Positive predictive value was found 62 % also. There were no association between the test values and age, parity or fasting state. We recommend all pregnant women should be screened at 24 week and then for gestational diabetes mellitus. We found this procedure easy to perform, economic and efficient.

___

  • 1. Alistair BR, Jhon RB,.Chiristino P, et al. Fructoseamine compared with a glucose load as a screening test for gestational diabetes obstet. Gynecol 1990; 76:773.
  • 2. Amakwah KS, Prentice PR, Fleuty FJ. The incidence of gestational diabetes. Obstet Gynecol 1977; 49:
  • 3. American Diabetes Association: Position Statement on Gestational Diabetes Mellitus. Diabetes1985; 34:123-6.
  • 4. American Diabetes association :Position statement on gestational diabetes mellitus. Diabetes Care1986;9:430.
  • 5. Carpenter MW coustan,D.R:Criteria for screening test for gestational diabetes. Am J Obstet Gynecol 1982;144:768.
  • 6. Carpenter MW: Rationale & Performance of test for gestational Diabetes & Gynecology Diabetes. 1991;134:3.
  • 7. Constan DR:Diabetes in pregnancy. In Feneroft AA, Martin RJ Neonatal perinatal medicine, 5th ed. Mosby year book, st.louis 1992; p199.
  • 8. Cousins L, Dattel BJ, Hollingsworth DR, et al. Glycosylated hemoglobin as a screening test for carbonhydrate intolerance in pregnancy. AmJ Obstet Gynecol, 1984;150:455.
  • 9. Coustan DR, Nelson A, Carpenter MW, et al. Should the fifty gram one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? Am J Obstet Gynecol 1986; 254:1031.
  • 10. Coustan DR, Nelson A, Carpenter MW, et al. Maternal age and screening for gestational diabetes a population based study. Obs & Gynecol 1989; 73:55.
  • 11. Cunningam FG, Mac Donald PC, Gant NF. Williams Obstetrics, 18th ed, Connecticut, Apple Large 1989; pp138-140.
  • 12. Dacus JV, Muram D, Moure WH, et al. Prenatal glucose Screening. The Journal of Reproductive Medicine1991;36:4.
  • 13. Dacus JV, Schula K, Sibai BM, Ruiz AG. Comparison of capillary and plasma glucose values in screening and oral glucose tolerance testing in pregnancy..The J of Rep Med 1990; 35:12.
  • 14. Fredericson H L Wilkins-Hang L. Ob/Gyn Secrets, Hanley & Belfus INC Publisers, Philadelphia 1991;p 152.
  • 15. Freikel N, Gabbe SC, Hadden R, et al. Summary & Recommandation of the second international workshop conferance on gestational DM. Diabetes 1985;34:123.
  • 16. Freikel N, Josimovich J. American Diabetes Association Workshop-conferance on gestational diabetes: Summary & Recommendations Diabetes Care1980; 3:455.
  • 17. Gebelikte glikoz toleransı.Kimler nasıl incelenmeli ? The Lancet 8621 pp1173-1174,1988 (Lancet Türkçe çeviri)
  • 18. Hall PM, Cook JGK, Shellen J. Glycosylated hemoglobin and glycosylated plasma protein in the diagnoses of diabetes mellitus and impaired glucose tolerance. Diabetes Care 1987;7:147.
  • 19. Johannes I, Polly F. Bancroft’s Introductıon to biostatistics, Second Edition, Harper and Row Publishers, New York 1970,
  • 20. Lavin JD. Screening of high risk and general populations for gestational diabetes. Clinical applications and cost analysis. Diabetes 1985;34:24.
  • 21. Margnelte GP, Klein VR, Nieblyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985; 2:7.
  • 22. Mills JL, Baker L, Goldmann AS. Malformations in diabetic mother occur before implications for treatment. Diabetes 1979; 28:292.
  • 23. National Diabetes Data Group: Classification and Diagnosis of Diabetes Mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039.
  • 24. Newton & Newton:Complications of Gynecologic and Obstetric Managemend, WB Saunders Company Philadelphia 1988; p 247.
  • 25. O’Sullivan J. Establishing criteria for gestational diabetes. Diabetes Care1980;3:437.
  • 26. O’Sullivan JB, Mahan CM, Charles D, et al. Screening criteria for high risk gestational diabetic patient. Am J Obstet Gynecol 1973;116:895.
  • 27. Sacs DA, Abu Fadil S, Phipps P, et al. How reliable is the fifty gram one hour glucose screening test/ Am J Obstet.Gynecol 1989;161:642-5.
  • 28. Shah BD, Cohan AN, Mayy C, et al. Comparison of glycohemoglobine determination and the identification of gestational diabetes. Am J Obstet Gynecol 1982; 144:774.
  • 29. Spellcy WN. Diabetes Mellitus ve Gebelik pp,479- 482, Çeviri editörü Erez,S Danfort’s obstetrics & Gynecology, 6,Yüce Yayınları İstanbul 1992; 1469 pp.
  • 30. Stangerber M, Persson B, Nordlanden E. Random capillary blood glucose and conventional selection criteria for glucose tolerance testing during pregnancy. Diabetes Res 1985;2:29.
  • 31. Widress JA, Schwarte HC, Kahn CB, et al. Glycohemoglobin in Diabetic Pregnancy a sequential Study. Am J Obstet Gynecol 1980; 136:1024.